0
Common-cold-induced T cells protect against SARS-CoV-2 infection
T cells from common colds caused by coronaviruses can further protect against COVID-19, as researchers demonstrate that higher levels of…
Browsing: Research > Basic
0
Benefit of breastmilk: COVID-19 antibodies pass from vaccinated mothers to infants
Study detects neutralizing antibodies against SARS-CoV-2 in stool samples of infants breastfed by vaccinated mothers with the potential to provide passive immunity against the…
0
Experimental enzyme shows promise as a prophylaxis to anthrax spores
Sometimes in experimental biology the very factor that is part of the disease-causing mechanism can also be the factor that…
0
COVID-19 autoantibodies: could sex influence susceptibility to long COVID-19?
Researchers report that COVID-19 can induce self-attacking autoantibodies persisting up to 6 months post-infection and demonstrate that males have more complex autoantibody responses to SARS-CoV-2 than females. A group of investigators from the Cedars-Sinai Medical Centre (CSMC; CA, USA), led by…
0
Hope for HIV: mRNA vaccine displays encouraging results in animal studies
A new mRNA HIV vaccine technology encodes key proteins to form virus-like particles (VLPs) that induce neutralizing antibodies safely and effectively in animal studies with minimal side effects. Researchers from…
0
Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis
This review, recently published in our partner journal Future Microbiology, discusses the pharmacology of oteseconazole and summarizes clinical studies investigating…
0
Whole-cell vaccines reimagined: a new method against recurrent UTI?
New encapsulating technology for whole-cell vaccines stimulates enhanced immunogenicity against Escherichia coli in a mouse model, shaping the future of urinary tract infection (UTI) vaccines. Recurrent…
0
HIV genome eliminated in an untreated patient for the second time
A second incidence of a HIV patient’s body eliminating intact HIV genomes without the aid of treatment has been discovered. …
0
Peek Behind the Paper: Pierre-Yves Lozach on Rift Valley fever virus
In this ‘Peek Behind the Paper’ feature, we take a look behind the scenes of a recent Perspective from the…
0
Drugs from nature: ethnobotany as a strategy for antimicrobial drug discovery
Plant natural products represent a largely untapped resource for discovering bioactive compounds to fill the antimicrobial drug development pipeline. With…